Financials

News Discussions Technicals Seasonals

2496 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Wuhan YZY Biopharma Co., Ltd. engages in the research, development, and industrialization of bispecific drugs. The firm specializes in tumor immunotherapy and immune cell therapy. Its business scope includes research and development of biotechnology, technology transfer, and technical advisory services; and wholesale and retail of biological drugs. The company was founded by Peng Fei Zhou, Qian Yuan, and Hong Feng Zhou on July 8, 2010 and is headquartered in Wuhan, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

2496 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company